AU2002218494A1 - Medicinal compositions and process for producing the same - Google Patents
Medicinal compositions and process for producing the sameInfo
- Publication number
- AU2002218494A1 AU2002218494A1 AU2002218494A AU1849402A AU2002218494A1 AU 2002218494 A1 AU2002218494 A1 AU 2002218494A1 AU 2002218494 A AU2002218494 A AU 2002218494A AU 1849402 A AU1849402 A AU 1849402A AU 2002218494 A1 AU2002218494 A1 AU 2002218494A1
- Authority
- AU
- Australia
- Prior art keywords
- producing
- same
- medicinal compositions
- medicinal
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000362727 | 2000-11-29 | ||
| JP2000-362727 | 2000-11-29 | ||
| PCT/JP2001/010417 WO2002043766A1 (en) | 2000-11-29 | 2001-11-29 | Medicinal compositions and process for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002218494A1 true AU2002218494A1 (en) | 2002-06-11 |
Family
ID=18833953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002218494A Abandoned AU2002218494A1 (en) | 2000-11-29 | 2001-11-29 | Medicinal compositions and process for producing the same |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002218494A1 (en) |
| WO (1) | WO2002043766A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI332407B (en) * | 2001-06-29 | 2010-11-01 | Takeda Chemical Industries Ltd | Controlled release composition and method of producting the same |
| EP1479684A4 (en) * | 2002-01-30 | 2006-01-04 | Takeda Pharmaceutical | THIENOPYRIMIDINES, PROCESS FOR THEIR PRODUCTION AND THEIR USE |
| SI1591446T1 (en) | 2003-01-29 | 2013-07-31 | Takeda Pharmaceutical Company Limited | Thienopyrimidine compounds and use thereof |
| MX2008000820A (en) * | 2005-07-22 | 2008-03-18 | Takeda Pharmaceutical | Premature ovulation preventive agent. |
| KR101522035B1 (en) | 2006-12-18 | 2015-05-20 | 다케다 야쿠힌 고교 가부시키가이샤 | Sustained-release composition and method for producing the same |
| WO2010026993A1 (en) * | 2008-09-03 | 2010-03-11 | 武田薬品工業株式会社 | Method for improving absorbability of preparation, and preparation having improved absorbability |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5195117A (en) * | 1975-02-12 | 1976-08-20 | Ridokainno 33 hidorokishi 22 nafutoesanenno seizoho | |
| JPH066534B2 (en) * | 1986-10-09 | 1994-01-26 | 積水化学工業株式会社 | Transdermal patch |
| CA2062659A1 (en) * | 1991-03-12 | 1992-09-13 | Yasutaka Igari | Composition for sustained-release of erythropoietin |
| EP0566135A1 (en) * | 1992-04-17 | 1993-10-20 | Takeda Chemical Industries, Ltd. | Transmucosal composition comprising a peptide and a cytidine derivative |
| EP0569096A1 (en) * | 1992-05-08 | 1993-11-10 | Akzo Nobel N.V. | Depot preparation |
| TW376319B (en) * | 1993-04-28 | 1999-12-11 | Janssen Pharmaceutica Nv | Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine |
| JP3701693B2 (en) * | 1993-12-28 | 2005-10-05 | 日本製薬株式会社 | Sustained release fat emulsion for injection containing analgesics |
| TW449600B (en) * | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
| JPH1045616A (en) * | 1996-08-02 | 1998-02-17 | Shionogi & Co Ltd | Sustained release preparation for injection |
| AU5678398A (en) * | 1997-01-29 | 1998-08-18 | Takeda Chemical Industries Ltd. | Sustained-release microspheres, their production and use |
| JPH11199521A (en) * | 1997-12-26 | 1999-07-27 | Lion Corp | External preparation for skin |
| EP1048301A4 (en) * | 1998-01-16 | 2005-03-09 | Takeda Chemical Industries Ltd | CONTROLLED RELEASE COMPOSITIONS, PROCESS FOR THEIR MANUFACTURE AND USE |
| TWI225863B (en) * | 1999-03-24 | 2005-01-01 | Takeda Chemical Industries Ltd | Thienopyrimidine compounds, their production and use |
-
2001
- 2001-11-29 AU AU2002218494A patent/AU2002218494A1/en not_active Abandoned
- 2001-11-29 WO PCT/JP2001/010417 patent/WO2002043766A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002043766A1 (en) | 2002-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6198700A (en) | Process for producing phenyl-alkanes compositions produced therefrom, and uses thereof | |
| AU2882201A (en) | Sustained-release preparation and process for producing the same | |
| AU2002224082A1 (en) | Dimethyl terephthalate composition and process for producing the same | |
| AU2000263163A1 (en) | Soft candies and process for producing the same | |
| AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
| AU2001255788A1 (en) | Improved endodontic instruments and process for producing the same | |
| AU2001267831A1 (en) | DDS compound and process for the preparation thereof | |
| AU2002214324A1 (en) | Medicinal compositions | |
| AU2001290239A1 (en) | Medicinal composition | |
| AU2002253642A1 (en) | Amorphous cefditoren pivoxil composition and process for producing the same | |
| AU2002218494A1 (en) | Medicinal compositions and process for producing the same | |
| AU2001252671A1 (en) | Pyridobenzodiazine derivatives and processes for the preparation thereof | |
| AU3193200A (en) | Tablets and process for producing the same | |
| AU2002229149A1 (en) | Process for producing hydrazinomonosaccharide derivatives and use thereof | |
| AU2001260083A1 (en) | New pharmaceutical composition and the process for its preparation | |
| AU2401401A (en) | Migrastatin, process for producing the same and medicinal compositions | |
| AU2001282541A1 (en) | Medicinal compositions | |
| AU2001283030A1 (en) | Process for making 3-hydroxyalkanenitriles and hydroxyaminoalkanes | |
| AU5462901A (en) | Process for the preparation of (pyridinylidene)-phthalides | |
| AU2001211674A1 (en) | Naphthomelanins, process for their preparation and compositions thereof | |
| AU2002216364A1 (en) | Novel substance fki-1083 and process for producing the same | |
| AU2000249111A1 (en) | New pharmaceutical composition and the process for its preparation | |
| AU2000228300A1 (en) | Novel substance fki-0076 and process for producing the same | |
| AU2001227071A1 (en) | Novel substance m-17a and process for producing the same | |
| AU4781000A (en) | 6-hydroxy-2-naphthylcarbinol and process for the preparation thereof |